FDA Approves At-Home Device for Treatment-Resistant Depression

(MedPage Today) -- The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker Neurolief announced on Tuesday.
ProlivRx is the first home-based prescription device to deliver focal...